Objection Handling in Pharma Sales: A Method, Example Scripts and the Rules You Must Respect

FreeScore your brand plan before management does. Send me the scorecard

Every rep remembers the call that went wrong. The doctor said “I’m happy with what I use”, the rep launched into three minutes of product benefits, and the doctor looked at the clock. Nothing the rep said was false. It was simply an answer to a question the doctor had not asked.

In more than twenty years of marketing medicines and consumer health products in Egypt, Saudi Arabia and the Gulf, I have sat through a great many debriefs with field teams. The pattern is consistent: reps rarely lose calls because they lacked an answer. They lose them because they answered too fast, answered the wrong concern, or said something they should not have said. This guide is about fixing all three, for medical reps who call on doctors and hospital pharmacists and for OTC reps who sell to pharmacy owners, pharmacists and chain buyers.

If you are new to the job itself, start with the guide to what a medical representative does. Objection handling is one part of a wider set of pharma selling skills, and it works best when the rest of the call is built well.

What Is Objection Handling in Sales?

An objection is any reason the customer gives for not doing what you are asking: not prescribing, not stocking, not listing, not meeting again. Handling it does not mean defeating it. It means finding out whether the concern is real, what lies behind it, and whether your product genuinely addresses it. Sometimes the honest answer is that it does not, and a good rep says so and moves to a patient type or a shelf where it does.

In pharmaceutical sales there is an extra layer. A medical rep’s answers are limited to what the regulator approved for the product and what the company’s medical and compliance teams cleared for promotion. A consumer goods salesperson can improvise; a pharma rep cannot. That makes preparation more important, not less.

What Counts as an Objection, and What Does Not?

The most common mistake is treating a question as an objection. “What about side effects?” is often a doctor checking whether the product suits a patient they already have in mind. If the rep becomes defensive, the doctor reads it as a sign that there is something to hide. The second mistake is treating a condition as an objection and arguing with it. No amount of persuasion in a clinic will put a product on a hospital formulary; that takes a separate process with the right people.

Why Are Objections a Good Sign in a Sales Call?

A doctor who says “my patients can’t afford it” has just told you that they pictured a patient on your product. A pharmacist who says “it doesn’t sell” has told you what would change their mind: evidence that it can sell. Objections are information. They show you what the customer values, what they fear, and what they believe about your product, which may be out of date.

The calls to worry about are the ones that end with “very good, thank you” and no commitment. The customer had a concern and chose not to share it. Over time, I have come to see a rep who reports no objections as a rep who is not asking enough questions, not one with an easy territory.

Can You Prevent Objections Before They Happen?

This is one of the central arguments of Neil Rackham’s SPIN Selling (1988), based on his team’s research into large numbers of real sales calls. Rackham observed that sellers who rushed to describe features and advantages tended to provoke more objections, because they were offering solutions to problems the customer had not yet agreed they had. His conclusion was that objection prevention matters more than objection handling: the strongest sellers received fewer objections because they spent the early part of the call asking about the customer’s situation and problems, and helping the customer see the implications of those problems for themselves.

For a medical rep, this means opening with questions about the patients the doctor sees, not with the product. “Which of your patients with this condition are hardest to manage?” leads to a very different call from “Let me tell you about Brand A.” For an OTC rep, it means asking the pharmacist what customers ask for at the counter before showing the promotion. If the need is clear and agreed, the product becomes an answer rather than an interruption.

Prevention does not remove every objection. Price, stock and formulary concerns will come anyway. But a rep who has asked first knows which concerns matter most to this customer, and can answer them in the customer’s own terms.

What Is the LAER Model, Step by Step?

The value of LAER is not that it is clever. It is that it puts two steps between hearing the objection and answering it, which is exactly where most reps go wrong. Here is how each step works in a pharmaceutical call.

1. Listen

Let the customer finish. Do not prepare your answer while they are speaking, and do not interrupt with “yes, but”. Note the exact words: “too expensive” and “my patients can’t afford it” are different objections. A short pause after the customer finishes shows that you took the point seriously.

2. Acknowledge

Show that you heard and understood, without agreeing that the objection is correct. “Cost is a real concern for many patients, I understand.” Acknowledging lowers the temperature. Skipping it makes the customer repeat the objection more firmly, because they do not feel heard.

3. Explore

Ask questions to find the real concern behind the words. This is the step most reps skip, and the most important. “When you say expensive, is it the monthly cost for the patient, or the comparison with another option?” “Was that a particular patient, or a general impression?” Often the first objection is not the real one. A doctor who says “I don’t have time” may really mean “I don’t see why this is relevant to me”.

4. Respond

Only now answer, and answer the concern you found, not the one you assumed. Keep it short, use only approved information and materials, and check that the answer landed: “Does that address what you had in mind?” If the customer is satisfied, move on to the next step of the call. If not, go back to exploring.

A good pharmaceutical sales rep training program teaches LAER early and then keeps returning to it in field coaching, because the habit of answering immediately is strong and comes back under pressure.

When Does Feel-Felt-Found Work, and When Does It Fail?

The formula is old and simple: “I understand how you feel. Other doctors have felt the same way. What they found was…” It works because it validates the concern and shows the customer is not alone in having it. For a pharmacy assistant worried about recommending a new product, or a patient-facing concern about tolerability, it can be a gentle bridge.

Its limits are real, and in pharma they matter more than elsewhere:

• The “found” must be true and approved. If what other doctors “found” is an anecdote about effectiveness, it becomes an unapproved claim. The “found” should point to approved information, not to stories.
• Never invent the “others”. Saying other doctors felt the same when you have no idea is a small lie, and customers often sense it.
• Experts dislike it. Specialists and experienced hospital pharmacists often hear the formula as a sales trick. They want you to engage with the clinical point, then offer the medical department if the question goes beyond your materials.
• It skips exploration. Used too early, it replaces the Explore step of LAER. Use it inside the Acknowledge step, then still ask your questions.

What Are the Most Common Objections a Pharma Rep Hears?

A note before the table. These responses are illustrations of structure, not scripts to read aloud. Each one starts by exploring, and each one avoids claims. Your own wording must come from your product’s approved information and the materials your medical and compliance teams have cleared. I have deliberately left out any clinical data, comparison or study result: in a real call, those come only from approved sources, and never from memory or from a competitor’s rumour.

Notice what the responses have in common. Each begins with a question or an acknowledgement, not an argument. None of them claims the product is better than anything else. When a clinical question goes beyond the approved materials, the answer is the medical department, not the rep’s own interpretation. And the side-effect objection triggers a duty: any report of an adverse event that a rep hears must go to the company’s pharmacovigilance function, whether or not the rep thinks it is related to the product.

FreeScore your brand plan before management does. Send me the scorecard

How Do You Answer “I’m Happy With My Current Brand”?

This is the objection reps hear most and handle worst, and behavioural science explains why. Daniel Kahneman and Amos Tversky’s Prospect Theory (1979) showed that people feel losses more strongly than gains of the same size. For a doctor, switching a patient to a new product carries a possible loss: the patient might do worse, or complain. The gain from switching feels smaller than that risk, even when it is not.

William Samuelson and Richard Zeckhauser named a related effect in 1988: status quo bias, the tendency to stick with the current option even when an alternative might be better. Their research showed that people choose an option more often simply because it is the one already in place. A prescribing habit is a status quo. So is a pharmacy’s usual order.

The practical lesson is that listing benefits does not overcome status quo bias. What helps is making the cost of the current situation visible, in the customer’s own terms. That is close to what Matthew Dixon and Brent Adamson describe in The Challenger Sale (2011). Their research into sales rep performance identified a profile they called the Challenger, who teaches the customer something new about their own situation, tailors the message to the person, and is willing to take control of the conversation. The core move is to reframe how the customer sees the problem before introducing the solution.

In a pharma call, reframing must be done carefully. You cannot challenge a doctor with unapproved claims or invented statistics. But you can ask questions that make a real gap visible: “Of the patients you started on it this year, how many are still taking it?” or “Which patients do you find yourself changing treatment for most often?” If the doctor names a gap, and your product’s approved indication fits it, you now have a reason to talk. If the doctor names no gap, accept it and ask about a different patient type. Pushing harder only strengthens the status quo.

How Do You Handle Price Objections in the Pharmacy?

Price objections in the pharmacy come in three forms, and each needs different reasoning.

“The margin is better on the competitor”

Margin per unit is only half of what a product earns. The other half is how many units sell. A product with a lower percentage margin that sells steadily can earn the pharmacy more cash in a month than a higher-margin product that sits on the shelf, and it ties up less money in stock. The way to show this is not to argue, but to work through the pharmacy’s own figures with the owner. Our pharmacy trade margin calculator makes the arithmetic quick: enter the prices and the monthly volumes the owner gives you, and compare what each option actually returns.

“It doesn’t sell, I have too much stock”

This is a rotation problem disguised as a price problem. Before offering a discount or a bonus on more stock, find out why it is not moving: shelf position, visibility, staff awareness, or the wrong product mix for that neighbourhood. Loading more stock into a pharmacy where the product does not move simply creates a returns problem next quarter. The broader view of how stock, shelf and staff work together is in the guide to pharmacy channel management in Saudi Arabia.

“It’s too expensive for my customers”

Pack price can mislead. Two products may have different pack sizes and different daily doses, so the honest comparison is the cost per day of treatment, or per full course, calculated from the approved dosing. Sometimes this shows your product costs less than it looks; sometimes it shows it really is more expensive, and then the answer is the value the approved information supports for the right customer, not a pretence that the price is low. For OTC products, staff who can explain that value at the counter matter more than any discount; see the guide to selling at the pharmacy counter.

In all three cases, resist the reflex to reach for a discount. Trade terms are a planned tool, set by the company’s trade marketing and key account teams, not a rep’s way out of an awkward call. The guide to trade marketing in the pharmaceutical industry explains how those terms should be designed.

What Must a Rep Never Say When Handling Objections?

Objections create pressure, and pressure is when reps say things they would never write down. In Saudi Arabia, the rules for promoting medicines are set by the Saudi Food and Drug Authority (SFDA) in its code of conduct for promotional practices, and most GCC regulators follow similar principles. Read the current version of the code yourself and follow your company’s interpretation of it; the practical checklist in our guide to SFDA marketing compliance is a good starting point. The lines below apply to every objection:

• No off-label talk. If a doctor asks about a use, a patient group or a dose outside the approved indication, do not answer it yourself, even to be helpful. Say it is outside what you can discuss and offer to have the medical department respond.
• No unsupported comparisons. “Ours works faster” or “it has fewer side effects” is a comparative claim. Unless it appears in approved materials backed by data, it cannot be said.
• No disparaging competitors. Criticising another brand, or hinting that a generic is of poor quality, damages your credibility and breaks the rules. Talk about your product, not theirs.
• No gifts or benefits in exchange for prescribing or stocking. Promising a gift, a trip or a personal favour to overcome an objection is not objection handling. The code sets strict limits on what may be given to healthcare professionals at all, and nothing may be linked to prescribing.
• No invented evidence. “A study showed…” must refer to a real study that appears in approved material. If you cannot cite it from an approved source, do not mention it.
• No dismissing side-effect reports. “That can’t be our product” is both wrong and a missed report. Record it and pass it on.

The same discipline applies to OTC and consumer health reps, though the rules differ by product category. A cosmetic, a supplement and a registered OTC medicine each carry different claim rules. When in doubt, say less and check.

How Does the Saudi and GCC Market Change the Answer?

A few regional patterns change how objections should be handled:

• Hospital lists are conditions, not preferences. Much of the hospital market in Saudi Arabia is supplied through formularies and procurement processes. “It’s not on the list” cannot be overcome in a clinic call. The work is to understand the hospital’s process, its pharmacy and therapeutics committee, and its timing, and to make sure the right people receive approved information.
• Chains decide centrally. In OTC, large pharmacy chains often make listing and shelf decisions at head office. A branch pharmacist who says “I can’t order it” may be stating a condition. The objection then belongs to the key account manager talking to the chain buyer, and the field rep’s job is to report it with detail.
• Insurance shapes price objections. For insured patients, the question is often whether the product is covered, not what it costs. Ask before assuming the patient pays.
• Trust comes before debate. In my experience across the Gulf, customers are more willing to share real objections with a rep they have come to trust over several visits. A rep who pushes hard on the first visit often hears only brush-offs. Consistency and honesty, including saying “I don’t know, I’ll find out”, build that trust faster than clever answers.
• Timing matters. Clinic and pharmacy hours shift during Ramadan, and “I don’t have time” is often literally true. Planning calls around the customer’s real schedule prevents a whole category of objections.

How Do You Build an Objection Bank Before a Cycle?

An objection bank is a shared document, usually a simple table, that collects the objections the team actually hears and the approved way to handle each one. It turns individual experience into team knowledge. Build it in four steps:

1. Collect. Ask every rep to log the exact words of objections from the last cycle, by product and customer type. Exact words matter; “price” is not specific enough.
2. Group. Merge similar objections and rank them by how often they appear and how much business they block.
3. Draft and approve. For each of the top objections, write the exploring questions and a response based on approved claims. Have the medical and compliance teams review the responses before anyone uses them.
4. Share and update. Brief the team at the cycle meeting, practise the top objections, and add new ones as they come in during the cycle.

The bank should hold questions as well as answers. The exploring questions are what reps forget under pressure, and they are what separates a good response from a defensive one.

How Should Reps Practise Objection Handling With Role-Play?

Role-play has a poor reputation because it is often done badly: long, artificial, and judged on performance rather than skill. Done well, it is the fastest way to build the habit of exploring before responding. A format that works:

• Pick one objection. Take it from the objection bank, preferably the one blocking the most business this cycle.
• Give the “customer” a brief. The colleague playing the doctor or pharmacist gets a hidden real concern behind the stated objection. The rep only finds it by exploring.
• Keep it short. A few minutes per round, then feedback, then another round with a different rep.
• Give specific feedback. Did the rep listen fully? Acknowledge? Ask at least two exploring questions? Stay within approved claims? Check that the answer landed?
• Swap roles. Playing the customer teaches reps how a defensive answer feels from the other side.

When Should You Walk Away and Come Back?

Not every objection should be handled in the moment. Some signs that it is time to close politely and return another day:

• The customer is clearly under time pressure or annoyed. Pushing on turns a temporary objection into a lasting one.
• The objection needs a medical answer beyond your approved materials. Promise the medical department will follow up, and make sure it does.
• You have explored and there is genuinely no patient or shelf where your product fits for this customer right now. Accept it, and keep the relationship.
• The objection is a condition, such as a formulary or a chain decision. Your effort belongs elsewhere.

Leaving well means summarising the concern, saying what you will do about it, and agreeing when you will return. Then come back with what you promised. A rep who follows up on a stated concern earns more credibility than one who wins an argument.

How Do Managers Coach Objection Handling on Ride-Alongs?

The ride-along is where objection handling is really learned, because it is where the habit of answering too fast shows up. Effective managers follow a simple routine:

1. Agree the focus before the call. “Today I’ll watch how you handle objections.” One focus per day is enough.
2. Stay silent in the call. If the manager takes over, the customer starts talking to the manager and the rep learns nothing. Step in only to prevent a compliance breach.
3. Write down the exact words. The customer’s objection and the rep’s first sentence in response. That first sentence tells you whether the rep explored or rushed.
4. Debrief with questions. “What do you think the real concern was?” “What else could you have asked?” Let the rep find the lesson.
5. Agree one change. One specific thing to try in the next call, and check it in the next call.
6. Feed the bank. New objections heard on ride-alongs go into the team’s objection bank.

What Are the Most Common Objection Handling Mistakes?

• Answering too fast. Responding before exploring, and answering a concern the customer did not have.
• Arguing. Winning the point and losing the customer. An objection is not a debate.
• Treating conditions as objections. Trying to persuade a doctor past a hospital list or a branch pharmacist past a chain decision.
• Going off-label to be helpful. The most damaging mistake, and the easiest under pressure.
• Criticising the competitor. It lowers your credibility and breaks the rules.
• Reaching for a discount. Using trade terms to escape a conversation, instead of finding the real concern.
• Reading scripts. Using a memorised response word for word, so the customer hears a technique instead of a person.
• Not following up. Promising information or a medical response and never delivering it.
• Ignoring side-effect reports. Every adverse event a rep hears must be passed to pharmacovigilance.

Key Takeaways

• Objection handling is understanding a concern and answering it honestly, not winning an argument
• Tell objections, questions, conditions and brush-offs apart; each needs a different response
• Prevent objections by asking about needs before presenting, as Rackham argued in SPIN Selling
• Use LAER: Listen, Acknowledge, Explore, Respond, and never skip the Explore step
• Feel-Felt-Found is a softener, not an answer, and its “found” must be true and approved
• Status-quo objections are about loss aversion; help the customer see a real gap rather than listing benefits
• In the pharmacy, separate price, margin and rotation, and work with the owner’s own numbers
• Stay inside approved claims and SFDA’s promotional code: no off-label, no unsupported comparisons, no gifts for business
• Build an objection bank each cycle, practise it in short role-plays, and coach it on ride-alongs

Frequently Asked Questions

What to Do Next

Write down the three objections you heard most last month, in the customer’s exact words. For each one, write two exploring questions you could have asked before answering. Then check your responses against your approved materials, and practise the hardest one with a colleague this week.

If you work in Saudi Arabia, booklet 04 of the Field Booklets, “Negotiation”, covers handling pressure and trade-offs with pharmacists and buyers, and booklet 05, “Relationships, Trust and Compliance”, covers building trust while staying inside the rules, both in Arabic and English. The first booklet is a free sample.